Cancer Drugs Market US$161.30 Bn by the end of 2021 at a CAGR of 7.4%

February 8, 2018 | Author: | Posted in Health
Cancer Drugs Market

Cancer Drugs Market

Zion Market Research has published a new report titled “Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, global cancer drugs market was valued at approximately USD 112.90 billion in 2015 and is expected to generate revenue of around USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.

Cancer can be defined as uncontrolled growth of the cell. Cancer starts when cells grow out of control and outnumber normal cells. Uncontrolled growth of cell leads to the formation of the tumor which can interfere with the nervous, digestive, and circulatory systems. Tumor cell releases hormones that alter body functions. Tumors that stay in one location and show limited growth are considered as benign cancer. Whereas, the cancerous cell which flows throughout the body part, using blood, lymph, and destroying the healthy tissue are called malignant cancer. According to the American Cancer Society, cancer is the second most common cause of death in the U.S. and accounts for nearly 1 of every 4 deaths. The World Health Organization estimates that, worldwide, there were 14 million new cancer cases and 8.2 million cancer-related deaths in 2012. There are over 200 different types of cancer, and each of which is classified by the type of cell that is initially affected. Various types of cancer include prostate cancer, blood cancer, lungs cancer etc. The treatment of cancer has become of prime importance owing to increase in a number of global cancer patients. Different types of drugs are administered to cancer patients depending upon therapy used to treat the patient and type of cancer.

Request Free Sample Research Report @  https://www.zionmarketresearch.com/sample/cancer-drugs-market

Growing incidences of target disease such as lung cancer, breast cancer, cervical cancer, etc. are expected to be the major driver for the global cancer drugs market. In addition, increasing research and development on biological and targeted drug therapies for the treatment of cancer coupled along with the expiration of patents is expected to trigger the growth of global cancer drugs industry in the coming years. However, the high price of drug development and stringent regulatory policies coupled along with the possibility of failure may pose the challenge to cancer drugs market. Nevertheless, increasing focus on personalized medicine coupled along with huge investment in anti-cancer drugs research across the globe are expected to act an opportunity for cancer drugs market in near future.

Based on therapeutics, cancer drugs market has been segmented into immunotherapy, targeted therapy, chemotherapy, hormone therapy and others. Immunotherapy segment is expected to grow at the fastest rate during the forecast period. The cancer drugs market is segmented based on cancer type into breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and others  In terms of revenue, blood cancer segment dominated the market in 2015.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/cancer-drugs-market

North America is expected to remain the dominant region over the forecast period. Increasing healthcare awareness is expected to boost the market in this region. Europe was the second largest market followed by Asia-Pacific. North America is expected to show fastest growth rate during the forecast period while Asia-Pacific market is projected to grow at a moderate rate during the forecast period. The Middle East and Africa, and Latin America are also expected to experience noticeable growth in the years to come.

Some of the key players in cancer drugs market include Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva Pharmaceuticals among others.

Browse detail report with in-depth TOC @ https://www.zionmarketresearch.com/report/cancer-drugs-market

About Us: Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research

244 Fifth Avenue, Suite N202

New York, 10001, United States

Tel: +49-322 210 92714

USA/Canada Toll-Free No.1-855-465-4651

Email: sales@zionmarketresearch.com

Website: http://www.zionmarketresearch.com                          

Visit Our Blog: https://zionmarketresearch.wordpress.com/

Facebook Comments

Author:

This author has published 29 articles so far. More info about the author is coming soon.

Leave a Reply

Facebook
Twitter
Google+
Pinterest
LinkedIn
RSS